ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

Michael Link Elected ASCO President.

January 15, 2010

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975